PuREC is a brand that specializes in regenerative therapeutic strategies using mesenchymal stem cells (MSCs). MSCs are multipotent cells that have the ability to differentiate into various mesenchymal lineage cells, including bone cells. With their low immunogenicity and proliferative capacity, MSCs hold great promise for therapeutic intervention in bone-related disorders.

Thanks to methodological advancements in isolating human bone marrow cells, PuREC is able to extract an extremely pure and rapidly expanding population of MSCs. These cells, known as rapidly expanding cells (REC), exhibit self-renewal and multilineage differentiation, making them highly valuable for regenerative therapy.

PuREC has developed an innovative in-vivo REC-MSC encapsulation and targeted delivery system. This system allows for the precise delivery of MSCs to the target tissues, promoting tissue repair and leveraging the body's natural self-repair system.

With a focus on hypophosphatasia and spinal canal stenosis, PuREC offers cutting-edge solutions that hold great potential for improving the lives of those affected by these conditions.

Experience the power of regenerative medicine with PuREC, the leading brand in regenerative therapeutic strategies.